Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
CC transcript
Quarterly results
Appointed director
|
|
ACURA PHARMACEUTICALS, INC (ACUR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| Brzeczko Albert W (VP, Pharma Sciences - APT) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 9,333 options to buy
@ $0
Exercised 34,000 options to buy
@ $0 |
|
| 08/05/2022 |
4
| Jones Robert B (President & CEO) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 13,666 options to buy
@ $0
Exercised 50,000 options to buy
@ $0 |
|
| 08/05/2022 |
4
| Seiser Robert A (VP, Controller & Treasurer) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 4,666 options to buy
@ $0
Exercised 20,000 options to buy
@ $0 |
|
| 08/05/2022 |
4
| CLEMENS PETER A (Senior VP & CFO) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 9,333 options to buy
@ $0
Exercised 40,000 options to buy
@ $0 |
|
| 03/18/2022 |
4
| Seiser Robert A (VP, Controller & Treasurer) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 03/18/2022 |
4
| Jones Robert B (President & CEO) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 03/18/2022 |
4
| CLEMENS PETER A (Senior VP & CFO) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 03/18/2022 |
4
| Brzeczko Albert W (VP, Pharma Sciences - APT) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 01/12/2022 |
4
| THANGARAJ IMMANUEL (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 66,666 options to buy
@ $0
Granted 66,666 options to buy
@ $0 |
|
| 01/11/2022 |
4
| WESSON BRUCE F (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 66,666 options to buy
@ $0
Granted 66,666 options to buy
@ $0 |
|
| 01/10/2022 |
4
| ROSS GEORGE K (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 66,666 options to buy
@ $0
Granted 66,666 options to buy
@ $0 |
|
| 01/05/2022 |
4
| SKELLY WILLIAM G (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 66,666 options to buy
@ $0
Granted 66,666 options to buy
@ $0 |
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Schutte John (10% Owner) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Converted 42,984,375 shares
@ $0.16, valued at
$6.9M
Converted convertible notes
@ $0.16, valued at
$0 |
|
| 05/28/2021 |
4
| WESSON BRUCE F (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Granted 66,666 options to buy
@ $0 |
|
| 05/28/2021 |
4
| ROSS GEORGE K (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Granted 66,666 options to buy
@ $0 |
|
| 05/28/2021 |
4
| SKELLY WILLIAM G (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Granted 66,666 options to buy
@ $0 |
|
| 05/28/2021 |
4
| THANGARAJ IMMANUEL (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Granted 66,666 options to buy
@ $0 |
|
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| THANGARAJ IMMANUEL (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 54,790 options to buy
@ $0 |
|
| 01/06/2021 |
4
| ROSS GEORGE K (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 54,790 options to buy
@ $0 |
|
| 01/06/2021 |
4
| WESSON BRUCE F (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 54,790 options to buy
@ $0 |
|
| 01/06/2021 |
4
| SKELLY WILLIAM G (Director) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Exercised 54,790 options to buy
@ $0 |
|
| 01/06/2021 |
4
| Seiser Robert A (VP, Treasurer & Controller) has filed a Form 4 on ACURA PHARMACEUTICALS, INC|
Txns:
| Paid exercise price by delivering 10,686 shares
@ $0.21, valued at
$2.2k
Exercised 4,667 options to buy
@ $0
Exercised 20,000 options to buy
@ $0 |
|
|
|
|